Annalisa Curcio

Title: **Innovator Spotlight: Annalisa Curcio**

Introduction

Annalisa Curcio is a distinguished inventor based in Torre Annunziata, Italy, celebrated for her contributions to the field of medicinal chemistry. With a focus on enhancing drug formulation, she has developed innovative solutions to improve the pharmacokinetic properties and reduce the toxicity of non-steroidal anti-inflammatory drugs (NSAIDs).

Latest Patents

Annalisa holds a patent for "Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug." This patented invention encompasses pro-drugs of all non-steroidal anti-inflammatories characterized by a free acid function derivatized with an ester group. The general structural formula includes various NSAIDs, such as aspirin, ibuprofen, and diclofenac, with the ester group potentially comprising a range of sugars and oligosaccharides.

Career Highlights

Annalisa has made significant strides in her career, showcasing her expertise while working with various companies, including Stewart Italia Srl. Her work has garnered attention for its potential to greatly improve therapeutic outcomes in pain management and inflammation reduction through innovative drug design.

Collaborations

Throughout her career, Annalisa has collaborated with notable individuals in her field, including Maria Grazia Rimoli and Antonio Calignano. These collaborations have fostered valuable exchanges of ideas and innovations, further advancing the development of her groundbreaking work in pharmacology.

Conclusion

Annalisa Curcio stands out as an influential inventor in the pharmaceutical landscape. Her innovative approaches to drug formulation not only address critical issues related to the efficacy of NSAIDs but also illustrate the potential for improved patient safety. As she continues her work, her contributions promise to impact the medical field positively.